Domestic SMEs often face pain points when trying to access the capital market, such as high profitability thresholds, long review periods, and significant uncertainty in the A-share market. In contrast, the US OTC market, with its low entry barriers and flexible trading mechanisms, has become a cost-effective option for companies seeking a tiered access to international capital markets. Among these options, OTC reverse takeovers (RTOs) are a mainstream solution for SMEs to quickly obtain US listing status due to their short processing time and high certainty.
I. What is an OTC reverse takeover (RTO)?
OTC reverse takeovers, also known as Real-Time Origin (RTO) listings, essentially involve acquiring the equity and management rights of a US OTC Markets-listed company to obtain listing status. The company then incorporates its own assets, business, and performance into the listed company, achieving indirect listing and subsequently raising funds and building its brand among global investors. Unlike the lengthy review process of traditional IPOs, RTOs, with their "list first, operate later, and then add value " logic, help companies quickly gain access to the US stock market.
II. Three-tier structure of the OTC market: Enterprises can match tiers as needed.
OTC Markets are one of the world's largest over-the-counter stock trading markets, accounting for over 75% of the total daily trading volume of securities in the United States. More than half of the world's and China's top 500 companies trade here. It is divided into three tiers:
- 1. OTCQX (highest tier): 638 companies in total. Positioned as the "best market", it is suitable for mature companies with high financial transparency and sound governance that wish to connect with institutional investors.
- 2. OTCQB (Intermediate Tier): A total of 1,166 companies, positioned as a "growth platform for entrepreneurial enterprises", suitable for developing startups and technology companies, and entities that have not yet met the financial standards of OTCQX.
- 3. OTCPink (Pink Sheets Marketplace): With over 10,000 companies, it is the lowest level of OTC market, suitable for various early-stage companies and entities with temporarily weak financial conditions, and can serve as a transitional bridge for starting capitalization.
III. Standard Timeline for OTC Backdoor Listings
A well-managed OTC backdoor listing follows a clear timeline, with key milestones that can be precisely controlled.
- 1. After signing the cooperation agreement, a high-quality OTC shell company will be identified within 5-10 working days, and the acquisition process will be initiated.
- 2. Acquire control of the shell company within 30 working days and complete the restructuring and merger;
- 3. Submit the new board members to the U.S. SEC within 30 business days to complete the change of ownership;
- 4. Within a period of 3 months to 2 years, complete the establishment of the red chip/VIE structure and the injection of assets and performance. Once the conditions are met, you can apply for a transfer to the Nasdaq or NYSE main board.
IV. The Core Value of OTC Backdoor Listing
- Quickly obtain listing status: Much shorter than the traditional IPO cycle, quickly obtain a US stock listing entity, enhance corporate brand credibility and financing endorsement;
- A tiered upgrade path: First, list on the OTC market and operate in a standardized manner; once performance targets are met, transfer to the main board to reduce the risks and costs of a one-time main board listing.
- Flexible financing tools: Using listed companies as the main body to carry out equity financing and industrial cooperation, thus broadening corporate financing channels.
Golden Box Group has been deeply involved in the cross-border capital market for 13 years, possessing a vast pool of high-quality OTC shell companies and a local Wall Street operation team. It provides a full-chain one-stop service from shell company selection, reverse acquisition, structuring, compliance auditing to main board transfer, and has helped many Chinese companies complete OTC listing and capitalization upgrade.